In Vitro Technologies Opens European Headquarters in biosaxony

Oct 18, 2005, 01:00 ET from biosaxony

    LEIPZIG, Germany, October 18 /PRNewswire/ -- Saxony's state minister for
 Economics and Labor, Thomas Jurk, welcomes the arrival of In Vitro
 Technologies GmbH (IVT) into the Bio City Leipzig. "I wish IVT a successful
 start in Europe. The decision of the US concern to locate to Leipzig shows
 that we have successfully developed Saxony into an attractive location for
 biotechnology," said Jurk. IVT produces cell-based test systems used in
 pharmaceutical and chemical-biological research.
     IVT is a wholly owned subsidiary of In Vitro Technologies, Inc. (IVT
 Inc), a leading company in the field of in vitro systems for drug discovery
 and development applications. IVT Inc.'s President and Chief Executive
 Officer, Dr. Paul M. Silber, commented: "Europe is of strategic importance to
 IVT's growth plans and a physical presence in Europe is a direct response to
 our customers needs for quick access to our products. Biosaxony's support was
 crucial in selecting Leipzig for our operations." Mr. Lalit Gaur, Sr. Manager
 Business Development of IVT Inc., further added: "The Bio City Leipzig offers
 us everything we need for a successful start in Europe: a cluster of
 internationally renowned researchers for potential collaborations,
 availability of trained and skilled technical staff, and optimal conditions.
 We need fast logistic access to our European markets for our time-critical
 products. With DHL, we can ship and deliver our products from Leipzig within
 24 hours."
     Dr. Hinnerk Boriss, European Manager for IVT, praised the support he
 received from the biosaxony team: "They arranged contacts to research
 scientists, accompanied the foundation of the German Company, and opened the
 doors to the most important contacts concerned with founding the company
 within the shortest period of time. The biosaxony Start-Up package
 facilitated a smooth transition from entry to establishment of business in
     IVT Inc. was founded in 1990 in Baltimore, Maryland, USA and currently
 employs over 70 people. IVT is a recognized leader in the development,
 production, sale and trade of in vitro testing products and services for
 studying chemical-biological interactions in vitro. One of its key products,
 Hepatocytes (liver cells), for example, is used in the early determination of
 clinical parameters (metabolism, drug-drug interactions) and toxicology
 profile for new drug candidates by the pharmaceutical and biotechnology
 industriesy. This is an essential step in testing new drug candidates. IVT
 produces cryogenically-preserved, in vitro cell products from human and
 animal hepatocytesspecies. The use of Tthese systems provides another
 alternative for animal testing and helps reduce the need for testing in
     Mr. Lalit Gaur
     In Vitro Technologies, Inc.
     1450 S. Rolling Road
     Baltimore, MD 21227
     Phone: +1-410-455-1242
     Dr. Hinnerk Boriss
     In Vitro Technologies GmbH
     Deutscher Platz 5 c
     04103 Leipzig
     Phone: +49-341-492-71-555

SOURCE biosaxony